John Enterman

John Enterman

Auto-generated profile, based on publicly available information

John Enterman

Parnassia Group for Mental Health Care

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
RWRemco Frank Peter de Winter
Remco Frank Peter de Winter
CMConnie M Meijer
Connie M Meijer
JEJohn H Enterman
John H Enterman
NKNienke Kool-Goudzwaard
Nienke Kool-Goudzwaard
MGManuela Gemen
Manuela Gemen
MGMarieke H de Groot
Marieke H de Groot
Background: Even though various types of suicidality are observed in clinical practice, suicidality is still considered a uniform concept. To distinguish different types of suicidality and consequently improve detection and management of suicidality, we developed a clinical differentiation model for suicidality. We believe that the model allows for a more targeted assessment of suicidal conditions and improves the use of evidence-based treatment strategies. The differentiation model is based on the experience with suicidality that we have encountered in clinical practice. This model distinguishes 4 subtypes of entrapment leading to suicidality. The earliest description of this model and a proposal for usability research has been previously presented in a book chapter. Objective: In this study, we present the most recent version of the 4-type differentiation model of suicidality and a protocol for a study into the usability of the proposed model. Methods: The 4-type differentiation model of suicidality distinguishes the following subtypes: (1) perceptual disintegration, (2) primary depressive cognition, (3) psychosocial turmoil, and (4) inadequate coping or communication. We plan to test the usability of the 4 subtypes in a pilot study of 25 cases, and subsequently, we will include 75 cases in a follow-up study. We looked at the case notes of 100 anonymized patients with suicidality who presented to mental health care emergency service in The Hague International Center. The summary and conclusions of the letters sent to the patients’ general practitioners after suicide risk assessment will be independently rated by 3 psychiatrists and 3 nurse-scientists for absolute and dimensional scores. The Suicidality Differentiation version 2 (SUICIDI-II) instrument, developed for this study, is used for rating all the cases. Intraclass correlation coefficients for absolute and dimensional scores will be calculated to examine type agreement between raters to examine the usability of the model and the feasibility of the SUICIDI-II instrument. Results: We consider the model tentatively valid if the intraclass correlation coefficients are ≥0.70. Subsequently, if the model turns out to be valid, we plan to rate 75 other cases in a follow-up study, according to a similar or adjusted procedure. Study results are expected to be published by the end of 2023. Conclusions: The theoretical roots of the differentiation model stem from classic and contemporary theoretical models of suicidality and from our clinical practice experiences with suicidal behaviors. We believe that this model can be used to adjust the diagnosis, management, treatment, and research of suicidality, in addition to distinguishing different dynamics between practitioners and patients with suicidality and their families. International Registered Report Identifier (IRRID): DERR1-10.2196/45438

31 December 2022 in JMIR Preprints
Verified
Preprint
Open access
RWRemco Frank Peter de Winter
Remco Frank Peter de Winter
CMConnie M Meijer
Connie M Meijer
JEJohn H Enterman
John H Enterman
NKNienke Kool-Goudzwaard
Nienke Kool-Goudzwaard
MGManuela Gemen
Manuela Gemen
MGMarieke H de Groot
Marieke H de Groot
BACKGROUND Even though various types of suicidality are observed in clinical practice, suicidality is still considered a uniform concept. To distinguish different types of suicidality and consequently improve detection and management of suicidality, we developed a clinical differentiation model for suicidality. We believe that the model allows for a more targeted assessment of suicidal conditions and improves the use of evidence-based treatment strategies. The differentiation model is based on the experience with suicidality that we have encountered in clinical practice. This model distinguishes 4 subtypes of entrapment leading to suicidality. The earliest description of this model and a proposal for usability research has been previously presented in a book chapter. OBJECTIVE In this study, we present the most recent version of the 4-type differentiation model of suicidality and a protocol for a study into the usability of the proposed model. METHODS The 4-type differentiation model of suicidality distinguishes the following subtypes: (1) perceptual disintegration, (2) primary depressive cognition, (3) psychosocial turmoil, and (4) inadequate coping or communication. We plan to test the usability of the 4 subtypes in a pilot study of 25 cases, and subsequently, we will include 75 cases in a follow-up study. We looked at the case notes of 100 anonymized patients with suicidality who presented to mental health care emergency service in The Hague International Center. The summary and conclusions of the letters sent to the patients’ general practitioners after suicide risk assessment will be independently rated by 3 psychiatrists and 3 nurse-scientists for absolute and dimensional scores. The Suicidality Differentiation version 2 (SUICIDI-II) instrument, developed for this study, is used for rating all the cases. Intraclass correlation coefficients for absolute and dimensional scores will be calculated to examine type agreement between raters to examine the usability of the model and the feasibility of the SUICIDI-II instrument. RESULTS We consider the model tentatively valid if the intraclass correlation coefficients are ≥0.70. Subsequently, if the model turns out to be valid, we plan to rate 75 other cases in a follow-up study, according to a similar or adjusted procedure. Study results are expected to be published by the end of 2023. CONCLUSIONS The theoretical roots of the differentiation model stem from classic and contemporary theoretical models of suicidality and from our clinical practice experiences with suicidal behaviors. We believe that this model can be used to adjust the diagnosis, management, treatment, and research of suicidality, in addition to distinguishing different dynamics between practitioners and patients with suicidality and their families. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/45438

2 February 2025 in medRxiv
Verified
Preprint
Open access
PDF file
VDViolet van Dee
Violet van Dee
SKSeyed Mostafa Kia
Seyed Mostafa Kia
CFCaterina Fregosi
Caterina Fregosi
WSWilma E. Swildens
Wilma E. Swildens
AAAnne Alkema
Anne Alkema
HSHugo G. Schnack
Hugo G. Schnack
BACKGROUND Predicting outcomes in schizophrenia spectrum disorders is challenging due to the variability of individual trajectories. While machine learning (ML) shows promise in outcome prediction, is has not yet been integrated into clinical practice. Understanding how ML models (MLMs) can complement psychiatrists’ predictions and bridge the gap between MLM capabilities and practical use is key. OBJECTIVE This study aims to compare the performance of psychiatrists and MLMs in predicting short-term symptomatic and functional remission in patients with first-episode psychosis and explore whether MLMs can improve psychiatrists’ prognostic accuracy. METHOD Twenty-four psychiatrists predicted symptomatic and functional remission probabilities based on written baseline information from 66 patients in the OPTiMiSE trial. ML-generated predictions were then shared with psychiatrists, allowing them to adjust their estimates. A questionnaire assessed trust in MLMs, perceived information gaps, and psychiatrists’ self-assessed predictive accuracy, which was compared to actual accuracy. FINDINGS The predictive accuracy of the MLM was comparable to that of psychiatrists for symptomatic remission (MLM: 0.50, psychiatrists: 0.52) and functional remission (MLM: 0.72, psychiatrists: 0.79). Interrater agreement was low but comparable for psychiatrists and the MLM. Although the MLM did not improve overall predictive accuracy, it showed potential in aiding psychiatrists with difficult-to-predict cases. However, psychiatrists struggled to recognize when to rely on the model’s output and we were unable to determine a clear pattern in these cases based on their characteristics. Psychiatrists could not reliably estimate their predictive accuracy. Psychiatrists expressed moderate to high trust in MLMs for prognostic prediction, but highlighted concerns about the lack of transparency and interpretability of model outputs. CONCLUSIONS MLMs are a promising tool for supporting psychiatric decision-making, particularly in challenging cases. However, their potential remains underutilized due to limitations in predictive accuracy and a lack of clarity in how predictions are generated. Addressing these issues is essential to build trust and foster integration into clinical practice. CLINICAL IMPLICATIONS MLMs are best suited as supplementary tools, providing a second opinion while psychiatrists retain decision-making autonomy. Integrating predictions from both sources may help reduce individual biases and improve accuracy. This approach leverages the strengths of MLMs without compromising clinical responsibility. What is already known on this topic While machine learning models (MLMs) show promise in predicting outcomes in psychotic disorders, they have yet to be integrated into clinical practice. Evidence on the predictive accuracy of psychiatrists for these disorders is limited, with only two small studies published before 1990 suggesting moderate accuracy. Comparisons of MLMs and psychiatrists in this context have not been previously conducted. What this study adds This is the first study to compare the predictive accuracy of psychiatrists with that of an MLM for psychotic disorders and to assess whether an MLM can enhance psychiatrists’ performance. It highlights that while MLMs do not improve overall accuracy, they may support psychiatrists in difficult cases. Insights into psychiatrists’ trust in MLMs and the challenges of implementing these models are also provided. How this study might affect research, practice, or policy The findings emphasize the need for advancements in MLM accuracy, interpretability, and strategies to identify cases where MLMs are most beneficial. These improvements could foster effective integration of MLMs as supplementary tools in clinical practice, aiding psychiatrists in decision-making while maintaining their autonomy.